Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2001 | 12-2000 | 09-2000 | 12-1999 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -928 | N/A | -21,009 | N/A |
| Depreciation Amortization | 12 | N/A | -27 | N/A |
| Accounts receivable | 23 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -33 | N/A | 122 | N/A |
| Other Working Capital | 37 | N/A | 97 | N/A |
| Other Operating Activity | 318 | 0 | 18,766 | 0 |
| Operating Cash Flow | $-573 | $N/A | $-2,051 | $N/A |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | 201 | N/A | 457 | N/A |
| PPE Investments | N/A | N/A | -1 | N/A |
| Other Investing Activity | 0 | 0 | -182 | 0 |
| Investing Cash Flow | $201 | $N/A | $273 | $N/A |
| Cash Flows From Financing Activities | ||||
| Common Stock Repurchased | -49 | N/A | -10 | N/A |
| Financing Cash Flow | $-49 | $N/A | $-10 | $N/A |
| Beginning Cash Position | 489 | N/A | 2,276 | N/A |
| End Cash Position | 69 | N/A | 489 | N/A |
| Net Cash Flow | $-420 | $N/A | $-1,788 | $N/A |
| Free Cash Flow | ||||
| Operating Cash Flow | -573 | N/A | -2,051 | N/A |
| Capital Expenditure | N/A | N/A | -1 | N/A |
| Free Cash Flow | -573 | 0 | -2,052 | 0 |